Insider Shareholders with Direct Ownership of Relmada Therapeutics, Inc. (RLMD)
This section provides a comprehensive overview of the insiders with direct ownership of Relmada Therapeutics, Inc. (RLMD). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RELMADA THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sergio Traversa
Chief Executive Officer |
738,298 | 79,767 | 734,024 $550,518 | 34 |
May 20, 2025
Added 16.75%
|
|
Paul Edward Kelly
Chief Operating Officer |
280,000 | 55,000 | 412,295 $309,221 | 22 |
May 16, 2025
Added 32.66%
|
|
Maged Shenouda
Chief Financial Officer |
322,107 | 36,000 | 288,335 $216,251 | 30 |
May 20, 2025
Added 17.22%
|
|
Chuck Ence
CA and CO |
267,931 | 0 | 267,931 $200,948 | 4 |
May 16, 2025
Added 46.08%
|
|
Cedric O'Gorman
Chief Medical Officer |
10,000 | 0 | 10,121 $7,590 | 1 |
May 23, 2023
Added 49.7%
|
|
Charles J Casamento
Director |
52,800 | 90,923 | 0 $0 | 18 |
Oct 22, 2024
Reduced 100.0%
|